These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33929638)

  • 61. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review.
    Ghosh-Swaby OR; Kuriya B
    Arthritis Res Ther; 2019 Jan; 21(1):33. PubMed ID: 30670075
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review.
    Tardito S; Martinelli G; Soldano S; Paolino S; Pacini G; Patane M; Alessandri E; Smith V; Cutolo M
    Autoimmun Rev; 2019 Nov; 18(11):102397. PubMed ID: 31520798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuromodulators for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008921. PubMed ID: 22258992
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.
    Gaujoux-Viala C; Nam J; Ramiro S; Landewé R; Buch MH; Smolen JS; Gossec L
    Ann Rheum Dis; 2014 Mar; 73(3):510-5. PubMed ID: 24395555
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular insights into phytochemicals exhibiting anti-arthritic activity: systematic review : John Di Battista.
    Sivasakthi P; Sanmuga Priya E; Senthamil Selvan P
    Inflamm Res; 2021 Jun; 70(6):665-685. PubMed ID: 34031706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Celecoxib for rheumatoid arthritis.
    Garner S; Fidan D; Frankish R; Judd M; Shea B; Towheed T; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2002; (4):CD003831. PubMed ID: 12519610
    [TBL] [Abstract][Full Text] [Related]  

  • 68. WITHDRAWN: Celecoxib for rheumatoid arthritis.
    Garner SE; Fidan D; Frankish RR; Judd M; Shea B; Towheed T; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003831. PubMed ID: 28598564
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Role of Natural Products in Rheumatoid Arthritis: Current Knowledge of Basic In Vitro and In Vivo Research.
    Deligiannidou GE; Gougoula V; Bezirtzoglou E; Kontogiorgis C; Constantinides TK
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33924632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.
    Schoels M; Knevel R; Aletaha D; Bijlsma JWJ; Breedveld FC; Boumpas DT; Burmester G; Combe B; Cutolo M; Dougados M; Emery P; van der Heijde D; Huizinga TWJ; Kalden J; Keystone EC; Kvien TK; Martin-Mola E; Montecucco C; de Wit M; Smolen JS
    Ann Rheum Dis; 2010 Apr; 69(4):638-643. PubMed ID: 20237123
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
    Heather EM; Payne K; Harrison M; Symmons DP
    Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review.
    Calvo Alén J; Pérez T; Romero Yuste S; Ferraz-Amaro I; Alegre Sancho JJ; Pinto Tasende JA; Maceiras Pan F; Quevedo JC; Hernández-Hernández MV; Hidalgo Calleja C; San Martín Álvarez A; Sánchez MIT; Sanmartí R
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):324-332. PubMed ID: 30241955
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.
    Navarro-Millán I; Sattui SE; Curtis JR
    Clin Ther; 2013 Nov; 35(11):1850-61.e1. PubMed ID: 24156821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.
    Aaltonen KJ; Virkki LM; Malmivaara A; Konttinen YT; Nordström DC; Blom M
    PLoS One; 2012; 7(1):e30275. PubMed ID: 22272322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rituximab treatment of refractory rheumatoid arthritis.
    Summers KM; Kockler DR
    Ann Pharmacother; 2005 Dec; 39(12):2091-5. PubMed ID: 16249269
    [TBL] [Abstract][Full Text] [Related]  

  • 77. What do we know about the safety of corticosteroids in rheumatoid arthritis?
    Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
    Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.
    Pan X; Lopez-Olivo MA; Song J; Pratt G; Suarez-Almazor ME
    BMJ Open; 2017 Mar; 7(3):e013242. PubMed ID: 28249848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
    Westlake SL; Colebatch AN; Baird J; Curzen N; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
    Rheumatology (Oxford); 2011 Mar; 50(3):518-31. PubMed ID: 21071477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis.
    Costa NT; Iriyoda TMV; Alfieri DF; Simão ANC; Dichi I
    Inflammopharmacology; 2018 Oct; 26(5):1151-1164. PubMed ID: 30062629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.